S&P 500

5.319,67

0,24%

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

TCBP

TC BioPharm (TCBP)

TC BioPharm Holdings PLC

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TCBP

1 2 3 4 5 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
15/05/2024	14h30	PR Newswire (US)	TCBP Announces Launch of Compassionate Use Program for TCB008	NASDAQ:TCBP	TC BioPharm Holdings PLC
06/05/2024	19h01	PR Newswire (US)	TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds	NASDAQ:TCBP	TC BioPharm Holdings PLC
06/05/2024	14h30	PR Newswire (US)	TC BioPharm Announces Execution of Second Non-Binding Letter of Intent for Acquisition, Targeting Innovative CAR-T Therapies	NASDAQ:TCBP	TC BioPharm Holdings PLC
04/04/2024	14h32	PR Newswire (US)	TCBP Announces Execution of Non-Binding Letter of Intent for Acquisition of NK Platform Technologies	NASDAQ:TCBP	TC BioPharm Holdings PLC
02/04/2024	14h30	PR Newswire (US)	TCBP Increasing Treatment Capacity with Expanded Manufacturing Process	NASDAQ:TCBP	TC BioPharm Holdings PLC
19/03/2024	13h30	PR Newswire (US)	TCBP Adjourns General Meeting Until a Later Date	NASDAQ:TCBP	TC BioPharm Holdings PLC
18/03/2024	13h30	PR Newswire (US)	TCBP Announces Exercise of Series D Warrants For Cash	NASDAQ:TCBP	TC BioPharm Holdings PLC
06/03/2024	12h30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCBP	TC BioPharm Holdings PLC
01/03/2024	14h30	PR Newswire (US)	Bryan Kobel, CEO of TCBP, Appears on Nationally Syndicated "The Big Biz Show"	NASDAQ:TCBP	TC BioPharm Holdings PLC
27/02/2024	23h15	PR Newswire (US)	/C O R R E C T I O N -- TC BioPharm/	NASDAQ:TCBP	TC BioPharm Holdings PLC
27/02/2024	14h30	PR Newswire (US)	TCBP Announces Shareholder Update Call on March 5th 2024	NASDAQ:TCBP	TC BioPharm Holdings PLC
22/02/2024	15h32	PR Newswire (US)	TCBP Announces MHRA Acceptance of Amendment for ACHIEVE UK Trial	NASDAQ:TCBP	TC BioPharm Holdings PLC
20/02/2024	12h05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:TCBP	TC BioPharm Holdings PLC
15/02/2024	14h30	PR Newswire (US)	TC BioPharm Management to Participate at Upcoming 7th CAR-TCR Summit Europe	NASDAQ:TCBP	TC BioPharm Holdings PLC
14/02/2024	20h48	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCBP	TC BioPharm Holdings PLC
14/02/2024	14h30	PR Newswire (US)	TCBP Provides Shareholder Update and Highlights Upcoming Milestones	NASDAQ:TCBP	TC BioPharm Holdings PLC
09/02/2024	21h26	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:TCBP	TC BioPharm Holdings PLC
29/01/2024	15h16	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:TCBP	TC BioPharm Holdings PLC
29/01/2024	14h30	PR Newswire (US)	TC BioPharm Chief Executive Officer, Bryan Kobel Featured on 'The Big Biz Show'	NASDAQ:TCBP	TC BioPharm Holdings PLC
18/01/2024	14h30	PR Newswire (US)	TC BioPharm to Present at the Sequire Investor Summit	NASDAQ:TCBP	TC BioPharm Holdings PLC
04/01/2024	14h46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TCBP	TC BioPharm Holdings PLC
04/01/2024	14h30	PR Newswire (US)	TC BioPharm Regains Compliance with Nasdaq Minimum Bid Price Requirement	NASDAQ:TCBP	TC BioPharm Holdings PLC
03/01/2024	14h30	PR Newswire (US)	TC BioPharm Announces Additional Cost Reduction Steps to Improve Financial Standing and Streamline Efficiencies	NASDAQ:TCBP	TC BioPharm Holdings PLC
22/12/2023	14h30	PR Newswire (US)	TC BioPharm Announces Closing of $3.5 Million Public Offering	NASDAQ:TCBP	TC BioPharm Holdings PLC
21/12/2023	23h14	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:TCBP	TC BioPharm Holdings PLC
19/12/2023	14h00	PR Newswire (US)	TC BioPharm Announces Pricing of $3.5 Million Public Offering	NASDAQ:TCBP	TC BioPharm Holdings PLC
19/12/2023	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:TCBP	TC BioPharm Holdings PLC
18/12/2023	17h15	PR Newswire (US)	TC BioPharm Announces Formation of Commercial Development Division, Led by Industry Veteran, Dr. Lauren Bor Ph.D	NASDAQ:TCBP	TC BioPharm Holdings PLC
14/12/2023	23h20	Edgar (US Regulatory)	Form F-1/A - Registration statement for certain foreign private issuers: [Amend]	NASDAQ:TCBP	TC BioPharm Holdings PLC
13/12/2023	15h05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:TCBP	TC BioPharm Holdings PLC